Pivotal: A Name Synonymous To Innovations

Pharmaceutical companies have been increasingly using outsourcing to be more efficient and effective in drug development, help reduce time-to-market and boost the ongoing commercial success of their products. This shift is accelerating M&A across many segments of outsourced pharmaceutical services. Across the pharmaceutical value chain, outsourced services are gaining traction, from drug discovery, contract research, and contract manufacturing to commercialization services, safety and risk management, and pharmaceutical IT.

CROs generally employ an expertise-driven, project-based consulting model that requires strategy and capability around managing complex trials. Most importantly, while some large service providers exist in this segment, significant consolidation opportunities exist. In comparison, the preclinical CRO market is more mature and consolidated. Over the years, many large pharmaceutical manufacturers have moved from working with a set of preferred providers to forming strategic partnerships with only one or two large CROs.

Nevertheless, other pharma and, preferably biotechnological, companies do still prefer to work with a set of qualified mid-size CROs in order to provide them with more personalized focused specialized services.

With the objective of becoming a reliable full-service CRO, Pivotal was born back in 2001 on the principle that strategic scientific and medical advice and support should be the backbone of all clinical trials with proper and sufficient resources to cover not only the execution of all essential aspects and stages of clinical trials from setup to execution to termination, including clinical monitoring and project management.

Under the leadership of Dr. Ibrahim Farr, Chairman, and CEO, Pivotal also oversees other complementary activities such as medical monitoring and writing support, or pharmacovigilance and data-management and biostatistical services, i.e., almost all that it takes to complete a clinical trial, while just leaving some very specialized tasks (e.g., drug depot services or lab. analytics) in the hands of very specialized vendors independent from the company.

Source:https://insightscare.com/pivotal-a-name-synonymous-to-innovations/